[RPRX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -33.20%
YoY- -25.25%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 537,267 538,202 535,955 554,963 510,932 457,608 3.25%
PBT 194,377 351,336 491,597 806,755 601,976 178,770 1.68%
Tax 92,373 123,711 187,093 365,979 159,902 88,044 0.96%
NP 102,004 227,625 304,504 440,776 442,074 151,713 -7.62%
Tax Rate -47.52% -35.21% -38.06% -45.36% -26.56% -49.25% -
Total Cost 435,263 310,577 231,451 114,187 68,858 305,895 7.30%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin 18.99 42.29 56.82 79.42 86.52 33.15 -10.53%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS 0.23 0.51 0.50 1.08 0.09 0.43 -11.75%
EPS Diluted 0.23 0.50 0.50 1.08 0.09 0.43 -11.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.